drugset / Trial / NCT00485017
Efficacy and Safety of THR-4109 in Obese Subjects
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the safety and effect of THR-4109 on weight loss in obese subjects over a 24-week treatment period.
Timeline
- Start
- 2007-08
- Primary completion
- 2008-06
- Completion
- 2008-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | THR-4109 | Unknown | 15 mg | Oral |
| Subject | THR-4109 | Unknown | 100 mg | Oral |
| Subject | THR-4109 | Unknown | 115 mg | Oral |